Lunai Bioworks PE Ratio 2013-2026 | LNAI
Current and historical p/e ratio for Lunai Bioworks (LNAI) from 2013 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lunai Bioworks PE ratio as of September 16, 2026 is 0.00.
| Lunai Bioworks PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-16 | 2.17 | 0.00 | |
| 2026-03-31 | 3.26 | $-61.12 | 0.00 |
| 2025-12-31 | 7.06 | $-60.32 | 0.00 |
| 2025-09-30 | 11.36 | $-63.28 | 0.00 |
| 2025-06-30 | 23.12 | $-86.40 | 0.00 |
| 2025-03-31 | 43.44 | $-38.48 | 0.00 |
| 2024-12-31 | 66.88 | $-81.68 | 0.00 |
| 2024-09-30 | 38.64 | $-83.68 | 0.00 |
| 2024-06-30 | 140.00 | $-72.80 | 0.00 |
| 2024-03-31 | 212.00 | $-92.80 | 0.00 |
| 2023-12-31 | 253.60 | $-56.00 | 0.00 |
| 2023-09-30 | 357.60 | $-56.80 | 0.00 |
| 2023-06-30 | 45.36 | $-56.80 | 0.00 |
| 2023-03-31 | 73.20 | $-160.80 | 0.00 |
| 2022-12-31 | 82.40 | $-164.00 | 0.00 |
| 2022-09-30 | 144.80 | $-168.00 | 0.00 |
| 2022-06-30 | 154.40 | $-172.80 | 0.00 |
| 2022-03-31 | 660.00 | $-65.60 | 0.00 |
| 2021-12-31 | 583.20 | $-63.20 | 0.00 |
| 2021-09-30 | 538.40 | $-57.60 | 0.00 |
| 2021-06-30 | 397.60 | $-45.60 | 0.00 |
| 2021-03-31 | 283.20 | $-23.20 | 0.00 |
| 2020-12-31 | 236.00 | $-18.40 | 0.00 |
| 2020-09-30 | 286.40 | $-16.80 | 0.00 |
| 2020-06-30 | 336.80 | $-20.00 | 0.00 |
| 2020-03-31 | 240.00 | $-8.80 | 0.00 |
| 2019-12-31 | 401.60 | $-12.00 | 0.00 |
| 2019-09-30 | 440.00 | $-44.80 | 0.00 |
| 2019-06-30 | 360.00 | $-38.40 | 0.00 |
| 2019-03-31 | 555.20 | $-48.00 | 0.00 |
| 2018-12-31 | 560.00 | $-52.00 | 0.00 |
| 2018-09-30 | 467.20 | $-22.40 | 0.00 |
| 2018-06-30 | 265.60 | $-23.20 | 0.00 |
| 2018-03-31 | 440.00 | $-14.40 | 0.00 |
| 2017-12-31 | 47.50 | $-7.20 | 0.00 |
| 2017-09-30 | 35.00 | $-8.80 | 0.00 |
| 2017-06-30 | 152.00 | $-13.60 | 0.00 |
| 2017-03-31 | 96.00 | $-23.20 | 0.00 |
| 2016-12-31 | 15.00 | $-22.40 | 0.00 |
| 2016-09-30 | 220.00 | $-17.60 | 0.00 |
| 2016-06-30 | 200.00 | $-14.40 | 0.00 |
| 2016-03-31 | 15.00 | $-18.40 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.000B |
| Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| 10x Genomics (TXG) | United States | $9.692B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Hims & Hers Health (HIMS) | United States | $6.498B | 0.00 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.157B | 32.86 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Veradigm (MDRX) | United States | $0.594B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| Standard BioTools (LAB) | United States | $0.271B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |